CANESTEN EXTERNAL ANTIFUNGAL CREAM 1 %
CLOTRIMAZOLE : 1 % · DIN 02239432 · BAYER INC
Health Canada status: MARKETED
What is CANESTEN EXTERNAL ANTIFUNGAL CREAM?
CANESTEN EXTERNAL ANTIFUNGAL CREAM 1 % contains CLOTRIMAZOLE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 02239432, held by BAYER INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 14-Feb-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CANESTEN EXTERNAL ANTIFUNGAL CREAM used for?
Treatment of vaginal candidiasis (1, 3, or 6-day regimens) and topical treatment of external irritation caused by vulvovaginal candidiasis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02239432 |
|---|---|
| Brand name | CANESTEN EXTERNAL ANTIFUNGAL CREAM |
| Generic / active ingredient | CLOTRIMAZOLE : 1 % |
| Manufacturer | BAYER INC |
| Strength | 1 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D01AC01 CLOTRIMAZOLE |
| AHFS class | 84:04.08.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 14-Feb-2020 |
| Original market date | 2000-06-02 00:00:00 |
How is it administered?
Vaginal: 1 applicator, tablet, or capsule (1, 3, or 6 days) at bedtime. External: Apply to irritated area 1-2 times daily for up to 7 days. Insert deep intravaginally.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store between 15°C - 30°C. Specific products (1 DAY/Combi 1 DAY) store between 15°C - 25°C.
How is it supplied?
Tubes (5g, 10g, 15g, 20g, 25g, 50g), pre-filled applicators, strips of 1 or 3 tablets/capsules. Available in various 'Combi' and 'Internal' packs.
Contraindications
Hypersensitivity to clotrimazole or any ingredient in the formulation.
Warnings and precautions
Not for oral or ophthalmic use. Seek medical advice if infections are frequent (returns <2 months), if diabetic, or immunocompromised. Discontinue if skin sensitization occurs.
What can be used instead?
Other Canadian products sharing ATC code D01AC01 CLOTRIMAZOLE. 4 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CANESTEN 1% TOPICAL CREAM | 1 % | CREAM | BAYER INC | MARKETED | DIN 02150867 |
| CLOTRIMADERM TOPICAL | 1 % | CREAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 00812382 |
| CLOTRIMAZOLE TOPICAL | 1 % | CREAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 02229380 |
| CANESTEN 1% TOPICAL SOLUTION | 1 % | SOLUTION | BAYER INC CONSUMER CARE | CANCELLED POST MARKET | DIN 02150875 |
| CANESTEN CRM 1% TOP | 1 % | CREAM | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | CANCELLED POST MARKET | DIN 02029502 |
| CANESTEN LIQ 1% | 1 % | LIQUID | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | CANCELLED POST MARKET | DIN 02029510 |
| CLOTRIMADERM TOPICAL SOLUTION 1% USP | 10 MG | LIQUID | TARO PHARMACEUTICALS INC | APPROVED | DIN 02236746 |
| MYCLO CRM 10MG | 10 MG | CREAM | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | CANCELLED POST MARKET | DIN 00516805 |
| MYCLO SOLUTION | 10 MG | LIQUID | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | CANCELLED POST MARKET | DIN 00516821 |
| MYCLO-DERM CREAM 1% | 10 MG | CREAM | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | CANCELLED POST MARKET | DIN 02131676 |
Who else supplies CLOTRIMAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CLOTRIMAZOLE appears in 169 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.